Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Tzamal Pharma is a leading Israeli healthcare company specializing in the marketing, sales, and distribution of pharmaceuticals and medical devices. As a key subsidiary of the Tzamal Medical Group, the company serves as a local representative for numerous global biotechnology and pharmaceutical giants, facilitating the entry of innovative treatments into the Israeli market. Their portfolio spans diverse therapeutic areas, including neurology, oncology, and rare diseases, with a strong focus on orphan drugs and specialized medical equipment. Tzamal Pharma provides comprehensive services ranging from regulatory affairs and market access to logistics and clinical support. The company is particularly noted for its expertise in managing Named Patient programs and compassionate use protocols for life-saving medications.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Tzamal Pharma.